Bluejay Diagnostics, Inc. Earnings Per Share (Basic)
Bluejay Diagnostics, Inc. (BJDX) reported Earnings Per Share (Basic) of -$1.12 per share for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareBasic · last filed 2026-08-12
- Bluejay Diagnostics, Inc. earnings per share, basic for the quarter ending 2026-06-30 was -$1.12.
- Bluejay Diagnostics, Inc. earnings per share, basic for the quarter ending 2026-03-31 was -$1.95.
- Bluejay Diagnostics, Inc. earnings per share, basic for the quarter ending 2025-12-31 was $0.83, a 98.65% decline year-over-year.
- Bluejay Diagnostics, Inc. earnings per share, basic for the quarter ending 2025-09-30 was -$1.01.
- Bluejay Diagnostics, Inc. earnings per share, basic for fiscal 2025 was -$15.25.
- Bluejay Diagnostics, Inc. earnings per share, basic for fiscal 2024 was -$456.75.
- Bluejay Diagnostics, Inc. earnings per share, basic for fiscal 2023 was -$3631.48.
- Bluejay Diagnostics, Inc. earnings per share, basic for fiscal 2022 was -$9.22.
| Period end | Earnings Per Share, Basic 3 month | Earnings Per Share, Basic 3 month as first filed | Earnings Per Share, Basic 6 month | Earnings Per Share, Basic 6 month as first filed | Earnings Per Share, Basic 9 month | Earnings Per Share, Basic 9 month as first filed | Earnings Per Share, Basic 12 month | Earnings Per Share, Basic 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | -$1.12 10-Q · filed 2026-08-12 | -$2.77 10-Q · filed 2026-08-12 | ||||||
| 2026-03-31 | -$1.95 10-Q · filed 2026-05-07 | |||||||
| 2025-12-31 | $0.83 derived: net income ÷ weighted average shares · filed 2026-03-06 | $41.77 derived: net income ÷ weighted average shares · filed 2026-03-06 | -$15.25 10-K · filed 2026-03-06 | |||||
| 2025-09-30 | -$1.01 10-Q · filed 2025-11-07 | -$4.62 10-Q · filed 2025-11-07 | ||||||
| 2025-06-30 | -$5.64 10-Q · filed 2026-08-12 | -$1.41 10-Q · filed 2025-08-07 | -$15.75 10-Q · filed 2026-08-12 | -$3.94 10-Q · filed 2025-08-07 | ||||
| 2025-03-31 | -$13.46 10-Q · filed 2026-05-07 | -$3.37 10-Q · filed 2025-05-13 | ||||||
| 2024-12-31 | $61.49 derived: net income ÷ weighted average shares · filed 2026-03-06 | -$192.30 derived: net income ÷ weighted average shares · filed 2026-03-06 | -$456.75 10-K · filed 2026-03-06 | -$114.19 10-K · filed 2025-03-31 | ||||
| 2024-09-30 | -$76.94 10-Q · filed 2025-11-07 | -$0.16 10-Q · filed 2024-11-07 | -$283.18 10-Q · filed 2025-11-07 | -$1.82 10-Q · filed 2024-11-07 | ||||
| 2024-06-30 | -$256.16 10-Q · filed 2025-08-07 | -$5.12 10-Q · filed 2024-08-14 | -$617.39 10-Q · filed 2025-08-07 | -$12.35 10-Q · filed 2024-08-14 | ||||
| 2024-03-31 | -$394.76 10-Q · filed 2025-05-13 | -$0.99 10-Q · filed 2024-05-15 | ||||||
| 2023-12-31 | -$3631.48 10-K · filed 2025-03-31 | -$9.08 10-K · filed 2024-03-28 | ||||||
| 2023-09-30 | -$16.67 10-Q · filed 2024-11-07 | -$2.08 10-Q · filed 2023-11-09 | -$58.38 10-Q · filed 2024-11-07 | -$7.30 10-Q · filed 2023-11-09 | ||||
| 2023-06-30 | -$22.00 10-Q · filed 2024-08-14 | -$2.75 10-Q · filed 2023-08-14 | -$41.95 10-Q · filed 2024-08-14 | -$5.24 10-Q · filed 2023-08-14 | ||||
| 2023-03-31 | -$2.49 10-Q · filed 2024-05-15 | -$0.12 10-Q · filed 2023-05-11 | ||||||
| 2022-12-31 | -$9.22 10-K · filed 2024-03-28 | -$0.46 10-K · filed 2023-03-20 | ||||||
| 2022-09-30 | -$2.94 10-Q · filed 2023-11-09 | -$0.15 10-Q · filed 2022-11-09 | -$6.86 10-Q · filed 2023-11-09 | -$0.34 10-Q · filed 2022-11-09 | ||||
| 2022-06-30 | -$2.00 10-Q · filed 2023-08-14 | -$0.10 10-Q · filed 2022-08-10 | -$2.00 10-Q · filed 2023-08-14 | -$0.20 10-Q · filed 2022-08-10 | ||||
| 2022-03-31 | -$0.10 10-Q · filed 2023-05-11 | |||||||
| 2021-12-31 | -$0.41 10-K · filed 2023-03-20 | |||||||
| 2021-09-30 | -$0.11 10-Q · filed 2022-11-09 | -$0.32 10-Q · filed 2022-11-09 | ||||||
| 2021-06-30 | -$0.15 10-Q · filed 2022-08-10 | -$0.20 10-Q · filed 2022-08-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| AETHLON MEDICAL INC (AEMD) | United States | $0.005B | |
| INTELLIGENT BIO SOLUTIONS INC. (INBS) | United States | $0.005B | |
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| Vivos Therapeutics, Inc. (VVOS) | United States | $0.003B | -0.26 |
| Sonoma Pharmaceuticals, Inc. (SNOA) | United States | $0.006B | -2.59 |
| NEXGEL, INC. (NXGL) | United States | $0.002B | |
| INVO Fertility, Inc. (IVF) | United States | $0.002B | -0.71 |